Medtech Company Active Needle Technology Overfunds On SyndicateRoom

Active Needle Technology, a medtech company that has claimed to develop a device designed to help doctors perform needle-based procedures with greater accuracy and reliability, has successfully secured £350,051 through its crowdfunding campaign on SyndicateRoom. The initiative overfunded to 140% of its £250,000 target.

Active Needle was founded by CEO Ian Quirk, who trained initially as a chemist before moving into product development and regulatory affairs and Senior Technical Officer Muhammad Sadiq, who is a Royal Society of Edinburgh (RSE) Enterprise Fellow. According to the company, by using technology developed at Dundee University, its new product notably addresses the core needle biopsy market. The device broadcasts its location onto the screen of conventional ultrasound detectors. Greater visibility of needles can improve the diagnostic process, allowing the doctor to proceed or adjust as needed.

Active Needle was featured in this quarter’s edition of Tech City News, as one of the ‘Rising Stars in UK Healthtech.’ Ian Quirk is also on the board of Lightpoint Medical, which was also funded via SyndicateRoom in December 2014, raising £989,998.

Quirk, who is also CEO of Active Needle, stated:

“Active Needle is committed to developing precision needle-based devices to improve accuracy during medical procedures, such as biopsies. The clinical impact of precision targeted needles includes increasing confidence of needle tip detection, whilst patients can benefit from reduced complications and discomfort. Funds raised via SyndicateRoom will be used to progress the device to pre-production standard, testing and into regulatory approval.” 

Gonçalo de Vasconcelos, CEO and Co-founder of SyndicateRoom, added:

“Active Needle is a clear example of a medtech innovator developing equipment to benefit both clinicians and patients, whilst providing potentially significant cost-saving benefits for the health sector, making the world a better place. We are delighted to welcome Active Needle as the latest medtech success story to join our company portfolio.”


Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!



Sponsored Links by DQ Promote

 

 

Disclosure Quest

Reg A - Form 1-A Filings Beta

Beta. Initial Form 1-A only. Target raise is the stated Amount to be Raised, totaled. Compared with the same dates one year earlier.

YTD: Jan 1, 2026 - Oct 24, 2026 vs Jan 1, 2025 - Oct 24, 2025

Share this graph
Number of Filings131Prior 126 +4.0%
Target Raise, Total$3.40BPrior $3.54B -3.9%
This YTDYear priorChange
Filings 131 126 +4.0%
Target raise $3.40B $3.54B -3.9%

Sponsored by the Crowded Media Group the leading digital news service covering the global Fintech Industry, including digital assets, crowdfunding, tokenization, and other innovations in capital markets. email us @CrowdfundInside

Source: DisclosureQuest. Initial Form 1-A only.

Created by Crowded Media Group

This display counts initial Form 1-A filings only. It does not represent subsequent filings, including Form 1-A/A amendments or Form 1-A POS post-qualification updates filed by the issuer. Amounts are the stated Amount to be Raised on the initial filing, not capital raised and not amounts revised in later filings.

0 0 votes
Article Rating
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Newest
Oldest Most Voted
 
0
Would love your thoughts, please comment.x
()
x
Send this to a friend